Further, several studies have repeatedly shown predictive value of copeptin (a stable biomarker of AVP) in relation to the metabolic syndrome, type 2 diabetes, and cardiovascular diseases [5, 18–21]. This evidence concerns the gene AVP and metabolic syndrome.